http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 01 May 2026 13:15:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html <p class="bwalignc"> <i>New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure Safe and Responsible Operations</i> </p> <p> STAMFORD, Conn.--(BUSINESS WIRE)-- Knoa Pharma LLC (“Knoa Pharma”) today begins operations as an independent company created to ensure safe access to medicines that are critical to patient care and to support communities with a purpose dedicated to abating the opioid crisis and improving public health. The company emerged following the conclusion of Purdue Pharma L.P.’s Chapter 11 proceedings on May 1, 2026, at which time Purdue permanently ceased operations. Established with the key stakeholders and http://www.streetinsider.com/Press+Releases/Knoa+Pharma+Begins+Operations+as+a+New%2C+Public+Health-Focused+Company+Dedicated+to+Supporting+Patients+and+Abating+the+Opioid+Crisis/26416053.html Fri, 01 May 2026 13:15:00 -0400 A.00134987 A.03350906 A.04794336 A.06993038 A.07460948 A.11693266 A.12432162 A.12874384 A.22771047 A.24312842 A.24672140 A.33603783 A.37422324 A.39379108 A.39942001 A.40132879 A.40161904 A.41533557 A.50114088 A.50114162 A.50200197 A.50214104 A.50216698 APTX DBD ENOV LH MA MRK O.00002577 O.00037438 O.00039210 O.00047314 O.00081820 O.00166927 O.00169247 O.00178988 O.00384665 O.00390287 O.00444833 O.00477968 O.00729045 O.01868273 O.02077532 O.02088108 O.03285413 O.05036542 O.07116395 O.10557543 O.15702083 O.20029655 O.20042566 O.20935137 O.21095532 O.28566330 O.38339246 O.41845222 O.50267127 O.61830915 RITM V